Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides
Open Access
- 1 April 1996
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 14 (5), 412-418
- https://doi.org/10.1016/0264-410x(95)00191-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.JCI Insight, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptidesEuropean Journal of Immunology, 1992
- Physico-chemical characterization of Intralipid™ emulsionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cellsEuropean Journal of Immunology, 1991
- H-2Kd-restricted antigenic peptides share a simple binding motif.The Journal of Experimental Medicine, 1991
- Histopathological studies on the local reactions induced by complete fReund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugatesThe Journal of Pathology, 1991
- Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.The Journal of Experimental Medicine, 1990
- Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsNature, 1990
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccineNature, 1989